Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [02/27/2026 14:55 PST] Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), Up By 100% ($3.31) From $3.31 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/27/2026 10:29 PST] Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), Up By 100% ($2.87) From $2.87 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/27/2026 10:29 PST] Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), Up By 100% ($5.31) From $5.31 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/26/2026 06:35 PST] CDIO Expected to Trade Up Short Term
• [02/25/2026 21:21 PST] Market Maker Surveillance Report. CDIO, Winning Stocks With Lowest Price Friction For Wednesday, February 25th 2026
• [02/25/2026 07:07 PST] CDIO Expected to Trade Up After Bullish Patterns Develop
• [02/23/2026 10:30 PST] Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), Up By 100% ($2.87) From $2.87 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/23/2026 07:18 PST] CDIO Expected to Trade Up After Bullish Patterns Develop
• [02/23/2026 06:51 PST] CDIO Expected to Trade Up Short Term
• [01/13/2026 07:17 PST] CDIO Expected to Trade Down After Bearish Patterns Develop
• [01/06/2026 07:31 PST] CDIO Expected to Trade Up After Bullish Patterns Develop